← All Articles

CUBEC Editorial

Seizing the Moment: Canada's Opportunity in Medtech & Biotech

Aditi Sitolay, CUBEC Co-founder and Board Member

March 2, 2025

The 'Made in Canada' movement is gaining traction, a welcome recognition of homegrown talent and innovation. However, we must move beyond simple labels and actively cultivate the fertile ground where Canada has the potential to truly excel but currently underperforms: the medtech and biotech sectors. We possess a wealth of intellectual capital, a foundation upon which a global powerhouse can be built.

As a biomedical engineering graduate from UBC, my experience pursuing postgraduate studies in the UK provided a crucial perspective. Only by experiencing other academic environments did I fully appreciate the depth and breadth of my Canadian education. The saying, "the grass is greener," proved true, but in an unexpected way. I realized the exceptional quality of my undergraduate training, particularly the unique blend of theoretical rigor and practical application.

Canadian universities, especially in engineering disciplines, excel at fostering hands-on experience. Co-op programs, internships, and dynamic design teams provide students with unparalleled opportunities to develop skills essential for real-world impact. This emphasis on practical application distinguishes our graduates, equipping them to lead in the rapidly evolving industry.

Beyond the talent pipeline, Canada boasts a robust tech ecosystem conducive to innovation. Our world-class universities, along with government support for research and development through generous tax incentives and non-dilutive funding, create a fertile environment for groundbreaking discoveries. We have the ingredients for success, but we must acknowledge the challenges that lie ahead.

To truly unlock our potential, we need to address the hurdles surrounding capital and regulatory pathways to commercialization. While our early-stage, non-dilutive R&D support is commendable, the journey from lab to market can be arduous and opaque. The primary challenge is capital. Obtaining early-stage, non-dilutive funding for proof-of-concept development is difficult, particularly for technologies not affiliated with universities. Moreover, securing risk-tolerant capital is crucial. Canada is known for its risk-averse investors, forcing many medtech and biotech startups to seek investment in the U.S. While securing some local capital is possible, it is often insufficient, hindering technological development. For larger funding rounds, U.S. investment becomes necessary. Although this may seem viable, it increases the pressure for companies to relocate to the U.S. Additionally, acquisitions often result in capital gains primarily benefiting U.S. investors. We need a more robust investment landscape, extending beyond medtech and biotech to encompass all industries.

Regarding the transition from bench to bedside, we can learn from international models, such as the FDA's interactive approach to regulatory requirements and the UK's establishment of dedicated health technology research centers. These initiatives facilitate a smoother transition from innovation to patient benefit, fostering a more vibrant medtech landscape.

Imagine a Canada where groundbreaking medical devices and life-saving therapies are seamlessly manufactured and deployed, both enriching our own healthcare system and impacting lives globally. Imagine a nation that attracts global investment and talent, becoming a premier hub for cutting-edge medical innovation. This vision is not a pipe dream; it's within our grasp.

We have the talent, the drive, and the foundation. Now we need action: streamlined regulations, greater transparency, and strong collaboration between academia, industry, and government. The 'Made in Canada' movement must be more than a slogan—it must drive our ambition to lead globally in all sectors, especially medtech and biotech. By nurturing talent, optimizing our ecosystem, and proactively commercializing, we can transform our scientific potential into a healthier, more prosperous future. Let's seize this moment and prove our strength.